LUNG CANCER, NONSMALL CELL
Clinical trials for LUNG CANCER, NONSMALL CELL explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER, NONSMALL CELL trials appear
Sign up with your email to follow new studies for LUNG CANCER, NONSMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing whether combining two existing drugs, tocilizumab and atezolizumab, can help control advanced non-small cell lung cancer that has stopped responding to initial immunotherapy. It will enroll about 28 adults to check if the combination is safe and if it shrink…
Matched conditions: LUNG CANCER, NONSMALL CELL
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Massive 12,000-Patient study aims to unlock secrets of lung cancer survival
Knowledge-focused Recruiting nowThis study aims to collect detailed information on 12,000 patients with lung and other chest cancers over many years. By tracking their treatments, health, and quality of life, researchers hope to understand why outcomes vary so much between patients. The goal is to use this real…
Matched conditions: LUNG CANCER, NONSMALL CELL
Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC